|
|
Volumn 10, Issue 1, 2003, Pages 85-91
|
|
Biotechnology M&A insight: Deals and strategies
|
|
Author keywords
Emerging sector; Fully integrated sector; Horizontal players; Merger and acquisitions
|
|
Indexed keywords
ADEFOVIR DIPIVOXIL;
ALEFACEPT;
ANTIBODY;
BETA1A INTERFERON;
EFALIZUMAB;
EMTRICITABINE;
ENZYME INHIBITOR;
EPTIFIBATIDE;
ETANERCEPT;
FROVATRIPTAN;
INFLIXIMAB;
INTEGRILLIN;
PROTEIN INHIBITOR;
RECOMBINANT HUMAN SERUM ALBUMIN;
RECOMBINANT INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;
RITUXIMAB;
TENOFOVIR DISOPROXIL;
ARTICLE;
BIOTECHNOLOGY;
COMMERCIAL PHENOMENA;
COMPETITION;
COOPERATION;
DRUG DELIVERY SYSTEM;
DRUG INDUSTRY;
ECONOMIC DEVELOPMENT;
ECONOMIC EVALUATION;
FINANCIAL MANAGEMENT;
MARKETING;
PROFIT;
|
|
EID: 3042736405
PISSN: 14628732
EISSN: None
Source Type: Journal
DOI: 10.1057/palgrave.jcb.3040058 Document Type: Article |
|
Times cited : (5)
|
|
References (0)
|
